Triomics
YC W21New York City, US · Founded 2021 · 50 employees · 3 known investors
Triomics builds AI systems for oncology teams that read full patient records and produce structured, auditable outputs for trial matching, visit preparation, and data curation. The company serves oncology clinics, trial matching networks, and quality reporting teams.
Founders & leadership· Y Combinator alumni (W21)
Sarim KhaninCo-Founder and CEO
Hrituraj Singhin𝕏Co-Founder and CTO
Investors · 3
In the news
- Funding Tracker '26: Clair lands $11.6M for hormone monitorfiercehealthcare.com · 2026
- Triomics has raised $22 Million in new funding - intelligence360intelligence360.news · 2026
- Trusted by Leading Cancer Centers to Solve Oncology’s Information Overload, Triomics Raises $22 Million to Accelerate Adoption | Healthcare IT Todayhealthcareittoday.com · 2026
- Triomics raises USD $22 million in Battery-led rounditbrief.co.uk · 2026
- Triomics raises $22M to fix oncology's data problemmed-tech.world · 2026
- How Triomics Uses AI To Help Doctors Treat Cancer More Quicklyforbes.com · 2026
- Triomics nabs $22M to bring oncology-specific AI to cancer centers | TechCrunchtechcrunch.com · 2026
- Savista partners with Triomics to launch industry’s first automated, full-stack cancer registry solutionktla.com · 2025